<DOC>
	<DOCNO>NCT02915367</DOCNO>
	<brief_summary>Next generation real-time monitoring PrEP adherence young Kenyan woman</brief_summary>
	<brief_title>Monitoring Pre-exposure Prophylaxis Young Adult Women</brief_title>
	<detailed_description>This protocol describe longitudinal study young Kenyan woman high risk HIV offer HIV pre-exposure prophylaxis ( PrEP ) two year . Adherence monitor woman next generation Wisepill ; half randomize receive short message service ( SMS ) reminder . The technical function , acceptability , cost , validity next generation Wisepill device couple SMS reminder determine among cohort young Kenyan woman . Additionally , SMS use longitudinal assessment risk perception alignment PrEP adherence .</detailed_description>
	<criteria>HIVuninfected ( determine Kenya national test algorithm ) Wanting start PrEP initial recommendation 6 month use Clinically safe receive PrEP , accordance Centers Disease Control Prevention ( CDC ) guideline : Creatinine clearance &gt; 60 mL/min Not infect hepatitis B No medical condition discretion site investigator would make participation unsafe complicate goal study Sexually active ( defined vaginal anal sex ) within last 3 month At high risk HIV infection base validate risk score &gt; 5 HIV serodiscordant relationship Not pregnant Owns personal cell phone ( share ) compatible study protocol ability charge Ability send text message Intending stay area least next year Willing use study criterion Unable provide consent Breastfeeding ( PrEPis currently approve use breastfeed ) Concurrent participation another research study may influence adherence PrEP and/or interfere procedure study .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>HIV/AIDS</keyword>
	<keyword>adherence</keyword>
	<keyword>woman</keyword>
	<keyword>real time monitoring</keyword>
	<keyword>risk</keyword>
	<keyword>SMS</keyword>
	<keyword>mHealth</keyword>
</DOC>